StockData
Ascendis Pharma A/S logo

Ascendis Pharma A/S (ASND) stock

ASNDNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Score 7/30
$271.19−0.54 (-0.20%)

Close on Nov 17, 2026Market cap $16.81BP/E 22.3Yield –

Ascendis Pharma A/S revenue

Revenue is the money a company takes in from selling its products and services, before any costs are deducted.

Ascendis Pharma A/S's revenue for the twelve months ending Jun 30, 2026 was €1.05B, up 113.4% year over year. For fiscal 2025 it was €720.13M, up 98.0% from the year before. Over ten years it grew 56.6% a year on average. The highest annual figure on record is €720.13M in fiscal 2025.

Annual revenue

PeriodPeriod endValueChange
FY2025Dec 31, 2025€720.13M+98.0%
FY2024Dec 31, 2024€363.64M+36.3%
FY2023Dec 31, 2023€266.72M+421.2%
FY2022Dec 31, 2022€51.17M+557.9%
FY2021Dec 31, 2021€7.78M+11.9%
FY2020Dec 31, 2020€6.95M-48.0%
FY2019Dec 31, 2019€13.38M+26.4%
FY2018Dec 31, 2018€10.58M+591.6%
FY2017Dec 31, 2017€1.53M-66.8%
FY2016Dec 31, 2016€4.61M-43.3%
FY2015Dec 31, 2015€8.12M–

Quarterly revenue

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026€339.29M+114.7%
Q1 FY2026Mar 31, 2026€246.60M+144.3%
Q4 FY2025Dec 31, 2025€247.50M+42.3%
Q3 FY2025Sep 30, 2025€213.63M+269.4%
Q2 FY2025Jun 30, 2025€158.05M+339.0%
Q1 FY2025Mar 31, 2025€100.95M+5.3%
Q4 FY2024Dec 31, 2024€173.92M+26.3%
Q3 FY2024Sep 30, 2024€57.83M+20.4%
Q2 FY2024Jun 30, 2024€36.00M-24.0%
Q1 FY2024Mar 31, 2024€95.89M+185.5%
Q4 FY2023Dec 31, 2023€137.70M+501.4%
Q3 FY2023Sep 30, 2023€48.03M+214.2%
Q2 FY2023Jun 30, 2023€47.39M+669.4%
Q1 FY2023Mar 31, 2023€33.59M+391.9%
Q4 FY2022Dec 31, 2022€22.90M+367.6%
Q3 FY2022Sep 30, 2022€15.29M+1273.8%
Q2 FY2022Jun 30, 2022€6.16M+502.7%
Q1 FY2022Mar 31, 2022€6.83M+815.3%
Q4 FY2021Dec 31, 2021€4.90M+815.3%
Q3 FY2021Sep 30, 2021€1.11M-59.6%
Q2 FY2021Jun 30, 2021€1.02M-28.8%
Q1 FY2021Mar 31, 2021€746.00K-66.5%
Q4 FY2020Dec 31, 2020€535.00K-78.7%
Q3 FY2020Sep 30, 2020€2.76M+22.9%
Q2 FY2020Jun 30, 2020€1.44M-55.3%
Q1 FY2020Mar 31, 2020€2.23M-58.9%
Q4 FY2019Dec 31, 2019€2.51M-76.2%
Q3 FY2019Sep 30, 2019€2.24M+11115.0%
Q2 FY2019Jun 30, 2019€3.21M+17738.9%
Q1 FY2019Mar 31, 2019€5.41M+19235.7%
Q4 FY2018Dec 31, 2018€10.52M+3655.4%
Q3 FY2018Sep 30, 2018€20.00K-95.4%
Q2 FY2018Jun 30, 2018€18.00K-95.9%
Q1 FY2018Mar 31, 2018€28.00K-92.5%
Q4 FY2017Dec 31, 2017€280.00K–
Q3 FY2017Sep 30, 2017€434.00K–
Q2 FY2017Jun 30, 2017€444.00K–
Q1 FY2017Mar 31, 2017€372.00K–

More Ascendis Pharma A/S figures

See a number that looks wrong?